Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial

NCT01498692 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01498692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01498692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2009
Completion date
May 31, 2015
Enrollment
94 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease